Opinion
Hsu: AI pharma commercial pitches outpace fundamental research breakthroughs
“I think in many ways the kind of pitch and the framing of these companies precedes The fundamental research capability breakthroughs.”
Assertion Not checkable as stated
Hsu: Current AI biological models are at GPT-1 or GPT-2 capability levels
“I find it helpful to frame these in terms of like GPT one, two, three, four, five capabilities, right? And I think most people would agree we're somewhere between GPT one and two, right?”
Assertion Partly supported
Hsu: GLP-1 market value exceeds 40 years of biotech startups combined
“The first is the amount of market cap added to Lilly and Novo based on the, you know, development of GLP ones. It's like over a trillion dollars is, is more, you know, I mean, NOAA stock has decreased a lot. So you know, trillion dollars, let's say, is more th…”
Prediction Not checkable as stated
Hsu: Physical synthesis and testing will remain AI drug discovery's bottleneck
“If we play this out, right? And let's say these AI models work, right? And you can make a trillion binders in silico that will, you know, be exquisite drug matter, right? We still need to make these things physically and test them in animals and hopefully pred…”
Insight
Hsu: Virtual cell models do not need mechanistic explanations to be useful
“And I would say similarly with a virtual cell model, it may not tell me literally why, just like a alpha fold doesn't tell me literally why did the protein fold this way and how, but it just told me the end state and it was reasonably accurate. I think that wo…”
Prediction Not checkable as stated
Hsu: Arc Institute's moonshot is building virtual cells using foundation models
“Our moonshot is really to make virtual cells at Arc and simulate human biology with foundation models, and, you know, we'd like to figure out something that feels useful for experimentalists, people who are skeptical about technology, you know, they just want …”
Insight
Hsu: Academic incentives actively discourage cross-disciplinary research collaboration
“Folks have their own incentive structures, right? They need to publish their own papers. They need to do their own thing and, you know, make their own discovery and, You're not really incentivized to work together.”
Opinion
Hsu: Modeling natural language and video is easier than modeling biology
“Natural language and video modeling is easier than modeling biology.”
Prediction Not checkable as stated
Hsu: Virtual cell models will advance from single cells to whole animals
“There are going to be different phases of capability where initially they model individual cells, then they model pairs of cells, then they model cells in a tissue, and then in a broader physiologically intact animal environment, and those are length scales an…”
Prediction Not checkable as stated
Hsu: Scaling single-cell screens alone will feel dated in three years
“We weren't just going to be an engineering shop that's just trying to scale single cell perturbation screens, right? That You know, would be interesting, but in three years would feel very dated, I think, right?”
Opinion
Hsu: Virtual cell modeling is more rigorous than digital twin concepts
“I think virtual cells, if anything, is actually way more scoped and rigorous than modeling a digital twin or avatar.”
Prediction Not checkable as stated
Hsu: Cell responses to chemical and environmental perturbations will be predictable
“Obviously, we want to be able to predict drug toxicity. We want to be able to predict aging. We want to be able to predict why a liver cell becomes cirrhotic when you repeatedly challenge it with ethanol molecules or whatever, right? And, you know, the, these …”
Prediction Open · timeframe Sep 2028
Hsu: Arc Institute will soon generate one billion perturbed single cells
“And at ARC in the next, you know, kind of end, like, I don't know, relatively short amount of time, we're going to generate a billion perturbed single cells, right?”
Opinion
Hsu: Multimodal biological models in AI biotech are currently mostly hype
“And then, you know, where there's hype is in Multimodal biological models, whatever that means, right?”
Insight
Hsu: Research groups struggle to excel at more than two disciplines
“It's very hard for individual research groups or individual companies to be good at more than two things, right?”
Disclosure
Hsu: Arc Institute focuses on Alzheimer's targets and virtual cells
“We have two flagship projects, one trying to find Alzheimer's disease drug targets, the other two make these virtual cells”
Opinion
Hsu: AI for protein design and binding has real-world heft
“There's heft in anything to do with proteins, right? Obviously protein binding, but increasingly in protein design, right? And I think there's real heft there.”
Prediction Not checkable as stated
Hsu: AI will become a native part of drug discovery in years
“I feel like in, you know, I mean, increasingly in just a few years, this will just be a native part of the stack, right? Just like we use You know, the internet and we use phones. We're going to have AI in all parts of the stack, right? And so it's just going …”
Assertion Not checkable as stated
Hsu: High-throughput biology is currently limited to imaging and sequencing
“Like, in biology, we ultimately have two ways to study it in high throughput. It's imaging and sequencing, right?”
Prediction Not checkable as stated
Hsu: Computer-use AI agents trail coding AI agents by one year
“I would say the computer use agents will probably trail the coding agents by maybe a year, right?”
Assertion Supported
Patrick Hsu: Arc Institute launched Virtual Cell Challenge with $100K in prizes
“We created our own virtual cell challenge at virtualcellchallenge.org where we have, you know, a 100,000 dollar prizes sponsored by NVIDIA and Tenex Genomics and Ultima and others.”
